DJIA 17,122.01 15.31 0.09%
NASDAQ 4,569.62 -1.02 -0.02%
S&P 500 2,000.12 0.10 0.00%
market minute promo


33.31 -0.09 (-0.27%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

YPF $33.31 -0.27%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.37
Previous Close $33.40
Daily Range $33.09 - $33.61
52-Week Range $16.63 - $41.74
Market Cap $13.1B
P/E Ratio 16.70
Dividend (Yield) $0.29 (0.5%)
Ex-Dividend Date
Dividend Pay Date
Volume 743,817
Average Daily Volume 2,812,096
Current FY EPS $2.79


Basic Materials



YPF S.A. (ADR) (YPF) Description

An integrated oil & gas company engaged in the exploration, development & production of oil & gas ('upstream'), as well as the refining, marketing, transportation & distribution of oil & a wide range of petroleum products/derivatives, petrochemicals, LPG. Website:

News & Commentary Rss Feed

Is It Time to Buy YPF Stock?

Argentinean energy company YPF is a particularly risky stock. However, the company also offers exceptional opportunities for growth in shale oil and gas. Is now the right time to buy YPF?

Argentina's Future Looks Bright

3 Stocks Dragging In The Energy Industry

Argentina: Focus On The Fundamentals

Argentina's Default: Should You Buy YPF?

5 Things YPF's Management Wants You to Know

Government ownership and economic uncertainty in Argentina are considerable reasons for uncertainty regarding YPF. On the other hand, the company is delivering solid financial performance, and opportunities for growth in areas such as shale production are remarkably exciting. Let´s go through YPF’s latest conference call and listen to what management has to say to investors.

10 biggest market-moving events this week

Is Now The Time To Invest In Argentina?

Monday's ETF Movers: EMLP, FM

Royal Dutch Shell Starts Bonga North West Project in Nigeria - Analyst Blog

See More YPF News...

YPF's Top Competitors

YPF $33.31 (-0.27%)
Current stock: YPF
BG $84.56 (0.45%)
Current stock: BG
PZE $6.32 (1.94%)
Current stock: PZE
CVE $31.38 (1.06%)
Current stock: CVE